Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews-Reference-Cited by-同舟云学术

Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews

Published:2018-09-18 Issue:6 Volume:89 Page:683-699
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Gilbert Emily W.¹^ORCID,Tay Chau T.¹²^ORCID,Hiam Danielle S.³,Teede Helena J.¹²^ORCID,Moran Lisa J.¹⁴^ORCID

Affiliation:

1. Monash Centre for Health Research and Implementation; School of Public Health and Preventative Medicine; Monash University; Clayton Victoria Australia

2. Department of Endocrinology and Diabetes; Monash Health; Clayton Victoria Australia

3. Institute of Health, Exercise and Sport; Victoria University; Melbourne Victoria Australia

4. Discipline of Obstetrics and Gynaecology; Robinson Research Institute; University of Adelaide; Adelaide South Australia Australia

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cen.13828/fullpdf

Reference71 articles.

1. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria;March;Hum Reprod,2010

2. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis;Lim;Hum Reprod Update,2012

3. Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia;Boyle;Med J Aust,2012

4. The relationship of menstrual irregularity to type 2 diabetes in Pima Indian women;Roumain;Diabetes Care,1998

5. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome;Chang;Fertil Steril,2014

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polycystic ovary syndrome and related inflammation in radiomics; relationship with patient outcome;Seminars in Cell & Developmental Biology;2024-02

2. Placental-derived mesenchymal stem cells restore ovarian function and metabolic profile in the rat model for polycystic ovarian syndrome;2024-01-25

3. Placental-derived mesenchymal stem cells improve ovarian folliculogenesis, imbalanced hormone levels, and metabolic parameters in an animal model of polycystic ovarian syndrome;2024-01-11

4. Polycystic ovary syndrome and nonalcoholic fatty liver disease;Polycystic Ovary Syndrome;2024

5. Introduction to polycystic ovary syndrome;Polycystic Ovary Syndrome;2024